Abstract
This chapter will discuss the role of cardiac fibroblasts as a target of various immunological inputs as well as an immunomodulatory hub of the heart through interaction with immune cell types and chemokine or cytokine signaling. While the purpose of this chapter is to explore the immunomodulatory properties of cardiac fibroblasts, it is important to note that cardiac fibroblasts are not a homogeneous cell type, but have a unique embryological origin and molecular identity. Specific properties of cardiac fibroblasts may influence the way they interact with the heart microenvironment to promote healthy homeostatic function or respond to pathological insults. Therefore, we will briefly discuss these aspects of cardiac fibroblast biology and then focus on their immunomodulatory role in the heart.
| Original language | English |
|---|---|
| Title of host publication | The Immunology of Cardiovascular Homeostasis and Pathology |
| Editors | Susanne Sattler, Teresa Kennedy-Lydon |
| Publisher | Springer |
| Chapter | 3 |
| Pages | 35-70 |
| Number of pages | 36 |
| Volume | 1003 |
| ISBN (Electronic) | 9783319576138 |
| ISBN (Print) | 9783319576114 |
| DOIs | |
| Publication status | Published - 2017 |
Publication series
| Name | Advances in Experimental Medicine and Biology |
|---|---|
| Volume | 1003 |
| ISSN (Print) | 0065-2598 |
| ISSN (Electronic) | 2214-8019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular disease
- Fibroblast
- Heart
- Immune response
- Immunomodulator
- Injury
- Myofibroblast
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver